MUNARI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 3.573
AS - Asia 2.102
EU - Europa 860
SA - Sud America 707
Continente sconosciuto - Info sul continente non disponibili 99
AF - Africa 55
OC - Oceania 2
Totale 7.398
Nazione #
US - Stati Uniti d'America 3.442
SG - Singapore 810
BR - Brasile 587
CN - Cina 410
HK - Hong Kong 356
VN - Vietnam 211
UA - Ucraina 131
DE - Germania 115
FR - Francia 98
TR - Turchia 89
RU - Federazione Russa 88
FI - Finlandia 87
IT - Italia 87
IE - Irlanda 85
GB - Regno Unito 83
BD - Bangladesh 59
AR - Argentina 51
CA - Canada 49
IN - India 33
ID - Indonesia 25
MX - Messico 22
ZA - Sudafrica 20
CO - Colombia 19
IQ - Iraq 17
BE - Belgio 15
CR - Costa Rica 14
EC - Ecuador 14
PK - Pakistan 13
SA - Arabia Saudita 13
JM - Giamaica 12
UZ - Uzbekistan 12
NL - Olanda 11
JP - Giappone 9
MA - Marocco 9
SE - Svezia 9
VE - Venezuela 9
CL - Cile 8
PL - Polonia 8
AE - Emirati Arabi Uniti 6
AT - Austria 6
NI - Nicaragua 6
PY - Paraguay 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
BB - Barbados 5
CH - Svizzera 5
CZ - Repubblica Ceca 5
NP - Nepal 5
EG - Egitto 4
ES - Italia 4
GT - Guatemala 4
IL - Israele 4
JO - Giordania 4
LB - Libano 4
MY - Malesia 4
PE - Perù 4
PH - Filippine 4
SV - El Salvador 4
AL - Albania 3
CI - Costa d'Avorio 3
DZ - Algeria 3
EE - Estonia 3
KE - Kenya 3
RS - Serbia 3
SC - Seychelles 3
AP - ???statistics.table.value.countryCode.AP??? 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
OM - Oman 2
SN - Senegal 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
GE - Georgia 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KR - Corea 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PW - Palau 1
SR - Suriname 1
Totale 7.300
Città #
Hong Kong 356
Singapore 350
Fairfield 320
The Dalles 251
Ashburn 242
San Jose 215
Council Bluffs 184
Woodbridge 157
Princeton 140
Seattle 138
Wilmington 125
Houston 112
Beijing 105
Jacksonville 104
Cambridge 103
New York 101
Helsinki 83
Istanbul 80
Lauterbourg 80
Dublin 79
Ho Chi Minh City 75
Los Angeles 64
North Bergen 61
Hanoi 58
Ann Arbor 57
Buffalo 41
São Paulo 41
Santa Clara 36
Redondo Beach 34
San Diego 32
Chicago 31
Des Moines 29
Moscow 28
Dallas 26
Rio de Janeiro 24
Orem 22
Shanghai 21
Chandler 18
London 18
Menlo Park 16
Brussels 15
Columbus 15
Brasília 14
Curitiba 13
Phoenix 13
Brooklyn 12
Tashkent 12
Belo Horizonte 11
Dhaka 11
Frankfurt am Main 11
San Francisco 11
Atlanta 10
Campinas 10
Montreal 10
Munich 10
San José 10
Buenos Aires 9
Denver 9
Johannesburg 9
Kingston 9
Nuremberg 9
Romola 9
Amsterdam 8
Boston 8
Düsseldorf 8
Elk Grove Village 8
Haiphong 8
Milan 8
Chennai 7
Contagem 7
Da Nang 7
Guayaquil 7
Paris 7
Philadelphia 7
Rome 7
Salt Lake City 7
Sorocaba 7
Toronto 7
Warsaw 7
Managua 6
Manchester 6
Norwalk 6
Salvador 6
The Bronx 6
Tokyo 6
Brno 5
Chiswick 5
Hải Dương 5
Joinville 5
Manaus 5
Miami 5
Montevideo 5
Poplar 5
Praia Grande 5
Queens 5
Recife 5
Stockholm 5
Thái Bình 5
Uberlândia 5
Wandsworth 5
Totale 4.535
Nome #
Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms 155
Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma 151
Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors 130
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma 126
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 118
Prevalence of PD-L1 expression in head and neck squamous precancerous lesions: a systematic review and meta-analysis 116
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 113
MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge 112
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 110
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 108
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 107
Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions 107
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine 104
Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma 101
⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer 101
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines 100
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 99
Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 98
ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder 97
Multiplex fluorescence in situ hybridisation to detect anaplastic lymphoma kinase and ROS proto-oncogene 1 receptor tyrosine kinase rearrangements in lung cancer cytological samples 96
PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263 96
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targets 96
“Interchangeability” of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy 96
Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma 95
Cyclin A1 expression predicts progression in pT1 urothelial carcinoma of bladder: a tissue microarray study of 149 patients treated by transurethral resection 95
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 95
Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker 92
Artificial intelligence applications for pre-implantation kidney biopsy pathology practice: a systematic review 91
Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma 91
Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies 91
Assessment of HER2 protein overexpression and gene amplification in renal collecting duct carcinoma: Therapeutic implication 91
Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection 89
Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases 89
PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non-Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists 89
The epidermal growth factor receptor is frequently overexpressed in penile squamous cell carcinomas: a tissue microarray and digital image analysis study of 112 cases 88
Human Innate Lymphoid Cells: Their Functional and Cellular Interactions in Decidua 86
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins 86
PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays 85
Dysregulation of mammalian target of rapamycin pathway in upper tract urothelial carcinoma 85
PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability 84
Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases 84
Human papillomavirus infection and immunohistochemical p16(INK4a) expression as predictors of outcome in penile squamous cell carcinomas 83
TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine 82
MicroRNA expression profiling of Xp11 renal cell carcinoma 82
Proximal CD13 Versus Distal GATA-3 Expression in Renal Neoplasia According to WHO 2016 Classification 81
Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes 81
Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases 81
Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy 81
Artificial intelligence in head and neck cancer diagnosis 80
Expression of programmed cell death ligand 1 in non-small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 Assay 80
Characterization of human NK cell-derived exosomes: Role of DNAM1 receptor in exosome-mediated cytotoxicity against tumor 80
Concurrent targeting of potential cancer stem cells regulating pathways sensitizes lung adenocarcinoma to standard chemotherapy 80
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 79
Non-small cell lung cancer: land of conquest for immunotherapy 78
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes? 75
PD-L1 expression heterogeneity in non-small cell lung cancer: defining criteria for harmonization between biopsies and whole sections 74
Strong association of insulin-like growth factor 1 receptor expression with histologic grade, subtype, and HPV status in penile squamous cell carcinomas: a tissue microarray study of 112 cases 74
Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer 73
Cathepsin k: A novel diagnostic and predictive biomarker for renal tumors 72
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems 71
Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma 71
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation 70
Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression 69
Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers 68
Challenges facing pathologists evaluating PD-L1 in head & neck squamous cell carcinoma 68
Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome 67
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 66
Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor 65
Validation of a Novel Three-Dimensional (3D Fusion) Gross Sampling Protocol for Clear Cell Renal Cell Carcinoma to Overcome Intratumoral Heterogeneity: The Meet-Uro 18 Study 63
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 63
MDM2 gene amplification as selection tool for innovative targeted approaches in PD-L1 positive or negative muscle-invasive urothelial bladder carcinoma 63
The immune checkpoint PD-1 in natural killer cells: Expression, function and targeting in tumour immunotherapy 62
Predicting progression in T1 non-muscle-invasive bladder cancer: back to histology 61
PD-1/pd-l1 in cancer: Pathophysiological, diagnostic and therapeutic aspects 61
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study 60
Immunotherapy targeting inhibitory checkpoints: The role of NK and other innate lymphoid cells 59
NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines 59
Wilms’ tumor primary cells display potent immunoregulatory properties on nk cells and macrophages 58
Exploiting Human NK Cells in Tumor Therapy 58
PD-L1 Expression in de Novo Metastatic Castration-sensitive Prostate Cancer 57
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 55
PD-L1 evaluation in head and neck squamous cell carcinoma: Insights regarding specimens, heterogeneity and therapy 51
Technical and Diagnostic Issues in Whole Slide Imaging Published Validation Studies 50
Pediatric tumors-mediated inhibitory effect on nk cells: The case of neuroblastoma and Wilms’ tumors 50
Program death ligand-1 immunocytochemistry in lung cancer cytological samples: A systematic review 48
Effect of Radio-Chemotherapy on PD-L1 Immunohistochemical Expression in Head and Neck Squamous Cell Carcinoma 47
Polymorphonuclear Myeloid-Derived Suppressor Cells Are Abundant in Peripheral Blood of Cancer Patients and Suppress Natural Killer Cell Anti-Tumor Activity 47
Inhibitory checkpoints in human natural killer cells: IUPHAR Review 28 45
PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation 43
Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword? 42
Histopathological evaluation and grading for prostate cancer: current issues and crucial aspects 22
Totale 7.398
Categoria #
all - tutte 53.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022293 0 0 0 0 4 7 9 56 84 29 34 70
2022/2023263 81 0 6 2 5 89 6 17 32 2 13 10
2023/2024539 17 14 12 96 14 70 11 27 181 2 4 91
2024/20251.240 4 9 11 118 127 84 132 31 163 175 244 142
2025/20262.805 227 421 305 532 182 90 301 113 250 225 120 39
2026/2027894 140 139 186 409 20 0 0 0 0 0 0 0
Totale 7.398